The American Diabetes Association (ADA) has selected Samuel Dagogo-Jack, MD, DSc, chief of the Division of Endocrinology, Metabolism, and Diabetes and director of the Clinical Research Center at the University of Tennessee Health Science Center, as the recipient of its 2024 Outstanding Achievement in Clinical Diabetes Research Award.
The award, which is one of the ADA’s National Scientific and Health Care Achievement Awards, recognizes Dr. Dagogo-Jack’s 30 years of exceptional contributions in patient-oriented clinical outcomes research. The ADA applauded his work for its significant impact on diabetes prevention and treatment and for providing critical insights into the pathobiology of prediabetes.
“When I entered the field, and even now, winning an award has never been my motivation. Our goal all along has been to increase knowledge and understanding of disease and to relieve human suffering,” Dr. Dagogo-Jack said. “Over the past decades, the focus of my research has been to dissect mechanisms that disrupt normal glucose regulation and move previously healthy individuals toward prediabetes and Type 2 diabetes. Along with that, we have also been engaged in testing new medications for diabetes treatment and novel approaches to the prevention of diabetes and its complications.”
As the A.C. Mullins Endowed Professor in Translational Research at UT Health Science Center, Dr. Dagogo-Jack continues to lead numerous studies on the origin and progression of prediabetes and diabetes, with funding amounting to more than $30 million from the National Institutes of Health, the ADA, and other organizations. He has published nine books, 23 book chapters, and more than 500 scientific papers in peer-reviewed journals.
Read more on our UTHSC news site.